Growth Metrics

Core Scientific (CORZ) Accumulated Expenses (2020 - 2026)

Core Scientific has reported Accumulated Expenses over the past 7 years, most recently at $364.5 million for Q1 2026.

  • Quarterly results put Accumulated Expenses at $364.5 million for Q1 2026, up 281.69% from a year ago — trailing twelve months through Mar 2026 was $364.5 million (up 281.69% YoY), and the annual figure for FY2025 was $512.0 million, up 691.65%.
  • Accumulated Expenses reached $364.5 million in Q1 2026 per CORZ's latest filing, down from $512.0 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $512.0 million in Q4 2025 and bottomed at $18.0 million in Q4 2022.
  • Median Accumulated Expenses over the past 5 years was $72.8 million (2022), compared with a mean of $138.0 million.
  • Peak annual rise in Accumulated Expenses hit 10417.75% in 2022, while the deepest fall reached 73.55% in 2022.
  • Over 5 years, Accumulated Expenses stood at $18.0 million in 2022, then soared by 900.65% to $179.6 million in 2023, then plummeted by 64.0% to $64.7 million in 2024, then soared by 691.65% to $512.0 million in 2025, then decreased by 28.81% to $364.5 million in 2026.
  • Business Quant data shows Accumulated Expenses for CORZ at $364.5 million in Q1 2026, $512.0 million in Q4 2025, and $358.3 million in Q3 2025.